Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
Baby KJ was the first to receive a bespoke gene-editing treatment. Personalized drugs for others could be approved within the ...
Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...
In his annual letter, Flagship Pioneering’s Noubar Afeyan lays out a choice between near-term “human-made miracles” and a ...
Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...
Morning Overview on MSN
Scientists engineer climate-proof queen bee to beat global warming
As heat waves intensify and seasons slip out of their old patterns, the survival of honey bees is becoming a test case for ...
We’re not just talking about fancy algorithms anymore; AI is actively changing how we interact with technology and how ...
CASGEVY® launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading ...
Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...
The "Molecular Biology for the Non-molecular Biologist Training Course (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets.com's offering.Elevate your expertise in molecular ...
NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...
In today's hyperconnected world, social media has become a critical channel for businesses to understand consumers. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results